コンテンツへスキップ
Merck
  • Proteomic profiling of SupT1 cells reveal modulation of host proteins by HIV-1 Nef variants.

Proteomic profiling of SupT1 cells reveal modulation of host proteins by HIV-1 Nef variants.

PloS one (2015-04-16)
Reshu Saxena, Sudipti Gupta, Kavita Singh, Kalyan Mitra, Anil Kumar Tripathi, Raj Kamal Tripathi
要旨

Nef is an accessory viral protein that promotes HIV-1 replication, facilitating alterations in cellular pathways via multiple protein-protein interactions. The advent of proteomics has expanded the focus on better identification of novel molecular pathways regulating disease progression. In this study, nef was sequenced from randomly selected patients, however, sequence variability identified did not elicited any specific mutation that could have segregated HIV-1 patients in different stages of disease progression. To explore the difference in Nef functionality based on sequence variability we used proteomics approach. Proteomic profiling was done to compare the effect of Nef variants in host cell protein expression. 2DGE in control and Nef transfected SupT1 cells demonstrated several differentially expressed proteins. Fourteen protein spots were detected with more than 1.5 fold difference. Significant down regulation was seen in six unique protein spots in the Nef treated cells. Proteins were identified as Cyclophilin A, EIF5A-1 isoform B, Rho GDI 1 isoform a, VDAC1, OTUB1 and α-enolase isoform 1 (ENO1) through LC-MS/MS. The differential expression of the 6 proteins was analyzed by Real time PCR, Western blotting and Immunofluorescence studies with two Nef variants (RP14 and RP01) in SupT1 cells. There was contrasting difference between the effect of these Nef variants upon the expression of these six proteins. Downregulation of α-enolase (ENO1), VDAC1 and OTUB1 was more significant by Nef RP01 whereas Cyclophilin A and RhoGDI were found to be more downregulated by Nef RP14. This difference in Nef variants upon host protein expression was also studied through a site directed mutant of Nef RP01 (55AAAAAAA61) and the effect was found to be reversed. Deciphering the role of these proteins mediated by Nef variants will open a new avenue of research in understanding Nef mediated pathogenesis. Overall study determines modulation of cellular protein expression in T cells by HIV-1 Nef variants.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
ヨードアセトアミド, Single use vial of 56 mg
Sigma-Aldrich
ヨードアセトアミド, BioUltra
Sigma-Aldrich
尿素, powder, BioReagent, for molecular biology, suitable for cell culture
Sigma-Aldrich
DL-ジチオトレイトール 溶液, BioUltra, for molecular biology, ~1 M in H2O
Supelco
DL-ジチオトレイトール 溶液, 1 M in H2O
Sigma-Aldrich
ヨードアセトアミド, ≥99% (NMR), crystalline
Sigma-Aldrich
尿素 溶液, BioUltra, ~8 M in H2O
Supelco
Urea, 8 M (after reconstitution with 16 mL high purity water)
Sigma-Aldrich
エチレンジアミン四酢酸 溶液, 0.02% in DPBS (0.5 mM), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
エチレンジアミン四酢酸, anhydrous, crystalline, BioReagent, suitable for cell culture
Sigma-Aldrich
エチレンジアミン四酢酸, 99.995% trace metals basis
Sigma-Aldrich
尿素, BioXtra, pH 7.5-9.5 (20 °C, 5 M in H2O)
Sigma-Aldrich
尿素, BioUltra, for molecular biology, 99% (T)
Sigma-Aldrich
尿素, suitable for electrophoresis
Sigma-Aldrich
エチレンジアミン四酢酸, ACS reagent, 99.4-100.6%, powder
Sigma-Aldrich
尿素, ACS reagent, 99.0-100.5%
USP
尿素, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
チオ尿素, ACS reagent, ≥99.0%
SAFC
ヨードアセトアミド
Sigma-Aldrich
尿素, meets USP testing specifications
Sigma-Aldrich
3-[(3-コールアミドプロピル)ジメチルアンモニオ]-1-プロパンスルホナート 水和物, 98%
Sigma-Aldrich
尿素 溶液, 40 % (w/v) in H2O
Sigma-Aldrich
エチレンジアミン四酢酸, anhydrous, BioUltra, ≥99% (titration)
Sigma-Aldrich
エチレンジアミン四酢酸 二ナトリウム塩 溶液, BioUltra, for molecular biology, pH 8.0, ~0.5 M in H2O
Sigma-Aldrich
チオ尿素, ReagentPlus®, ≥99.0%
Sigma-Aldrich
エチレンジアミン四酢酸, purified grade, ≥98.5%, powder
Sigma-Aldrich
尿素, ReagentPlus®, ≥99.5%, pellets
Sigma-Aldrich
尿素, ≥99.0%
Sigma-Aldrich
Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe, ≥97% (HPLC)